| Literature DB >> 17991829 |
Nobuhiko Kayagaki1, Qui Phung, Salina Chan, Ruchir Chaudhari, Casey Quan, Karen M O'Rourke, Michael Eby, Eric Pietras, Genhong Cheng, J Fernando Bazan, Zemin Zhang, David Arnott, Vishva M Dixit.
Abstract
Production of type I interferon (IFN-I) is a critical host defense triggered by pattern-recognition receptors (PRRs) of the innate immune system. Deubiquitinating enzyme A (DUBA), an ovarian tumor domain-containing deubiquitinating enzyme, was discovered in a small interfering RNA-based screen as a regulator of IFN-I production. Reduction of DUBA augmented the PRR-induced IFN-I response, whereas ectopic expression of DUBA had the converse effect. DUBA bound tumor necrosis factor receptor-associated factor 3 (TRAF3), an adaptor protein essential for the IFN-I response. TRAF3 is an E3 ubiquitin ligase that preferentially assembled lysine-63-linked polyubiquitin chains. DUBA selectively cleaved the lysine-63-linked polyubiquitin chains on TRAF3, resulting in its dissociation from the downstream signaling complex containing TANK-binding kinase 1. A discrete ubiquitin interaction motif within DUBA was required for efficient deubiquitination of TRAF3 and optimal suppression of IFN-I. Our data identify DUBA as a negative regulator of innate immune responses.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17991829 DOI: 10.1126/science.1145918
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728